These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6388425

  • 1. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G, Böhme H, Heidrich H, Heinrich F, Hirche H, Maass U, Mörl H, Rudofsky G.
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [Abstract] [Full Text] [Related]

  • 2. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
    Adhoute G, Bacourt F, Barral M, Cardon JM, Chevalier JM, Cuny A, Gillet M, Juhan C, Leguay G, Marion J.
    Angiology; 1986 Mar; 37(3 Pt 1):160-7. PubMed ID: 3518547
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R, Valentin A, Stöllberger C, Slany J.
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [Abstract] [Full Text] [Related]

  • 5. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 6. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühl U.
    Dtsch Med Wochenschr; 1984 May 11; 109(19):745-50. PubMed ID: 6373217
    [Abstract] [Full Text] [Related]

  • 7. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
    Schmidt C, Royer RJ, Kissel P.
    Therapie; 1974 May 11; 29(6):915-23. PubMed ID: 4618388
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
    Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel JP, Quancard X.
    J Cardiovasc Pharmacol; 1990 May 11; 16 Suppl 3():S75-80. PubMed ID: 1369725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1131-4. PubMed ID: 823407
    [Abstract] [Full Text] [Related]

  • 11. The effect of naftidrofuryl (Praxilene) on intermittent claudication.
    Waters KJ, Craxford AD, Chamberlain J.
    Br J Surg; 1980 May 03; 67(5):349-51. PubMed ID: 6992910
    [Abstract] [Full Text] [Related]

  • 12. [Naftidrofuryl in arterial obstructive disease: A systematic revue of the literature].
    Bourrion B, Hazard A, Baltazard H, Sebbag P, Fournier L, François M.
    Rev Med Interne; 2020 Feb 03; 41(2):89-97. PubMed ID: 31669163
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a vasoactive substance, naftidrofuryl, during the rehabilitation phase after an ischaemic insult.
    Ducarne H.
    Curr Med Res Opin; 1986 Feb 03; 10(1):58-71. PubMed ID: 3698655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J, Guidicelli H, Glanddier G, Mosnier M.
    Ann Cardiol Angeiol (Paris); 1994 Nov 03; 43(9):542-7. PubMed ID: 7864561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S.
    Vasa Suppl; 1988 Nov 03; 24():38-43. PubMed ID: 3212602
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
    Abendroth D, Sunder-Plassmann L.
    Vasa Suppl; 1988 Nov 03; 24():33-7. PubMed ID: 3212601
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.